PFE -
Pfizer Inc.
25.65
-0.02 (-0.08%)
As of January 23, 2026 4:00 pm EST
Quote Detail
| Last | 25.65 |
|---|---|
| Change | -0.02 |
| Change % | -0.08 |
| Bid | 25.6 X 2500 |
| Ask | 25.61 X 100 |
| Volume | 45.4 M |
| Shares | 5.69 B |
| Market Cap | 148.4 B |
| Open | 25.58 |
|---|---|
| High | 25.69 |
| Low | 25.51 |
| Prev Close | 25.67 |
| 52 Wk High | 27.69 |
| 52 Wk Low | 20.92 |
| EPS | 1.7243 |
| P/E | 15.21 |
| Div Yield | 6.71 |
Market Headlines
PADCEV" Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
TOKYO and NEW YORK, Dec. 17, 2025 /PRNewswire via COMTEX News Network/ -- -- PADCEV plus Keytruda is the first and only regimen without platinum-based chemotherapy to improve event-free and overall...
Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement
SHANGHAI, Dec. 9, 2025 /PRNewswire via COMTEX News Network/ -- Fosun Pharma (SSE: 600196; HKEX: 02196) today announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Limited. ("Yao...
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
Dec 02, 2025 (Investor Brand Network via COMTEX News Network) -- BioMedWire Editorial Coverage: Chronic conditions and rare diseases in the aging population present an urgent and expanding...
